Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Gene therapy of X-linked severe combined immunologic deficiency (SCID-X1)].

Pathologie-biologie - 1 Feb 2001

Hacein-Bey S, Gross F, Nusbaum P, Yvon E, Fischer A, Cavazzana-Calvo M

Abstract excerpt

X-linked severe combined immunodeficiency (SCID-X1) is a recessive hereditary disorder in which early T and Natural Killer (NK) lymphocyte development is blocked. The genetic disorder results from mutations in the common gamma c chain that participates in several cytokine receptors including the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, CD34
Share to Bone Marrow
Share to Gene Transfer, Horizontal

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Therapy

Share to Hematopoietic Stem Cells

Share to Receptors, Cytokine

Share to Severe Combined Immunodeficiency

Share to X Chromosome

Source

Identifiers

PMID: 11265225
DOI: 10.1016/s0369-8114(00)00002-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026. Prepared record publication-11265225-2026-08-31.1. Manifest publication-graph-cohort-2026-08-31.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 31 Aug 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Gene therapy of X-linked severe combined immunologic deficiency (SCID-X1)].PMID 11265225Read ↗

Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease.Semantic proximity Read ↗

[Gene therapy of SCID-X1].Semantic proximity Read ↗

Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiencySemantic proximity Read ↗

Immune Reconstitution After Gene Therapy Approaches in Patients With X-Linked Severe Combined Immunodeficiency DiseaseSemantic proximity Read ↗

Gene Therapy for X-Linked Severe Combined Immunodeficiency: Where Do We Stand?Semantic proximity Read ↗

X-linked severe combined immunodeficiency: from molecular cause to gene therapy within seven years.Semantic proximity Read ↗

Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector.Semantic proximity Read ↗

Preclinical Development of a Lentiviral Vector for Gene Therapy of X-Linked Severe Combined ImmunodeficiencySemantic proximity Read ↗

Gene therapy for severe combined immunodeficiencies and beyondSemantic proximity Read ↗

X-linked severe combined immunodeficiency syndrome: the first Korean case with gamma c chain gene mutation and subsequent genetic counseling.Semantic proximity Read ↗

Treatment of an infant with X-linked severe combined immunodeficiency (SCID-X1) by gene therapy in Australia.Semantic proximity Read ↗

Gene therapy for severe combined immune deficiencySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.